HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tam, S. P. Articles by Kisilevsky, R. Search for Related Content PubMed PubMed Citation Articles by Tam, S. P. Articles by Kisilevsky, R. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 43, 1410-1420, September 2002
Copyright © 2002 by Lipid Research, Inc.

Promoting export of macrophage cholesterol

Shui Pang Tam^*,, Alana Flexman^,, Jennifer Hulme^*, and Robert Kisilevsky^1,*,,

^* Department of Biochemistry, Queen's University
Department of Pathology, Queen's University
The Syl and Molly Apps Research Center, Kingston General Hospital, Kingston, Ontario, Canada K7L 3N6

¹ To whom correspondence should be addressed. e-mail: kisilevsky{at}cliff.path.queensu.ca

We show that murine macrophages that have ingested cell membranes as a source of cholesterol exhibit a marked increase in acyl-CoA:cholesterol acyl tranferase (ACAT) activity. Exposure of these macrophages to acute-phase high-density lipoprotein (HDL) results in a marked reduction of ACAT and enhancement of cholesteryl ester hydrolase (CEH) activities, phenomena not seen with native HDL. These complementary but opposite effects of acute-phase HDL on the two enzyme systems that regulate the balance between esterified (storage) cholesterol and unesterified (transportable) cholesterol are shown to reside with serum amyloid A (SAA) 2.1, an acute-phase apolipoprotein of HDL whose plasma concentration increases 500- to 1,000-fold within 24 h of acute tissue injury. Mild trypsin treatment of acute-phase HDL almost completely abolishes the apoliporotein-mediated effects on the cholesteryl ester cycle in cholesterol-laden macrophages. The physiological effect of SAA2.1 on macrophage cholesterol is to shift it into a transportable state enhancing its rate of export, which we confirm in tissue culture and in vivo.

The export process is shown to be coupled to the ATP binding cassette transport system. Our findings integrate previous isolated observations about SAA into the sphere of cholesterol transport, establish a function for a major acute-phase protein, and offer a novel approach to mobilizing macrophage cholesterol at sites of atherogenesis.

Abbreviations: AP-HDL, acute-phase high density lipoprotein; apoA-I, apolipoprotein A-I; CEH, cholesterol ester hydrolase; LPDS, lipoprotein depleted serum; RBC, red blood cell; T-AP-HDL, trypsin-modified acute-phase high density lipoprotein

Supplementary key words HDL • SAA • cholesterol • inflammation • macrophages

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. S. Getz and C. A. Reardon SAA, HDL biogenesis, and inflammation J. Lipid Res., February 1, 2008; 49(2): 269 - 270. [Full Text] [PDF]

				S.-P. Tam, L. Mok, G. Chimini, M. Vasa, and R. G. Deeley ABCA1 mediates high-affinity uptake of 25-hydroxycholesterol by membrane vesicles and rapid efflux of oxysterol by intact cells Am J Physiol Cell Physiol, September 1, 2006; 291(3): C490 - C502. [Abstract] [Full Text] [PDF]

				D. R. van der Westhuyzen, L. Cai, M. C. de Beer, and F. C. de Beer Serum Amyloid A Promotes Cholesterol Efflux Mediated by Scavenger Receptor B-I J. Biol. Chem., October 28, 2005; 280(43): 35890 - 35895. [Abstract] [Full Text] [PDF]

				S. P. Tam, J. B. Ancsin, R. Tan, and R. Kisilevsky Peptides derived from serum amyloid A prevent, and reverse, aortic lipid lesions in apoE-/- mice J. Lipid Res., October 1, 2005; 46(10): 2091 - 2101. [Abstract] [Full Text] [PDF]

				K. D. O'Brien, T. O. McDonald, V. Kunjathoor, K. Eng, E. A. Knopp, K. Lewis, R. Lopez, E. A. Kirk, A. Chait, T. N. Wight, et al. Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 785 - 790. [Abstract] [Full Text] [PDF]

				I. N. Baranova, T. G. Vishnyakova, A. V. Bocharov, R. Kurlander, Z. Chen, M. L. Kimelman, A. T. Remaley, G. Csako, F. Thomas, T. L. Eggerman, et al. Serum Amyloid A Binding to CLA-1 (CD36 and LIMPII Analogous-1) Mediates Serum Amyloid A Protein-induced Activation of ERK1/2 and p38 Mitogen-activated Protein Kinases J. Biol. Chem., March 4, 2005; 280(9): 8031 - 8040. [Abstract] [Full Text] [PDF]

				A. Chait, C. Y. Han, J. F. Oram, and J. W. Heinecke Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res., March 1, 2005; 46(3): 389 - 403. [Abstract] [Full Text] [PDF]

				L. Cai, M. C. de Beer, F. C. de Beer, and D. R. van der Westhuyzen Serum Amyloid A Is a Ligand for Scavenger Receptor Class B Type I and Inhibits High Density Lipoprotein Binding and Selective Lipid Uptake J. Biol. Chem., January 28, 2005; 280(4): 2954 - 2961. [Abstract] [Full Text] [PDF]

				V. G. Cabana, N. Feng, C. A. Reardon, J. Lukens, N. R. Webb, F. C. de Beer, and G. S. Getz Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro J. Lipid Res., February 1, 2004; 45(2): 317 - 325. [Abstract] [Full Text] [PDF]

				R. Kisilevsky and S. P. Tam Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 J. Lipid Res., December 1, 2003; 44(12): 2257 - 2269. [Abstract] [Full Text] [PDF]